Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans.
Vogt A, Mahé B, Costagliola D, Bonduelle O, Hadam S, Schaefer G, Schaefer H, Katlama C, Sterry W, Autran B, Blume-Peytavi U, Combadiere B.
Vogt A, et al. Among authors: schaefer h, schaefer g.
J Immunol. 2008 Feb 1;180(3):1482-9. doi: 10.4049/jimmunol.180.3.1482.
J Immunol. 2008.
PMID: 18209043
Clinical Trial.